Adverum Biotechnologies, Inc.: cash_and_equivalents
| Value | {"amount": 247082000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2016-03-31) |
| Status | current |
| Entity | Adverum Biotechnologies, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:01:42.416243+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b91bf3dd-1a32-4b3e-b8f1-888870c9a57d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-16-018295Retrieved: 2026-08-19T15:01:42.416243+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001501756/cash-and-equivalents/2016-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b91bf3dd-1a32-4b3e-b8f1-888870c9a57d
History
- no predecessors — first report